Author:
Dudek Arkadiusz Z.,Zolnierek Jakub,Dham Anu,Lindgren Bruce R.,Szczylik Cezary
Reference13 articles.
1. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007
2. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007
3. BAY-43-9006 exhibits broad oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis;Wilhelm;Cancer Res,2004
4. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship;Mendel;Clin Cancer Res,2003
5. Randomized phase 2 trial of first-line treatment with sorafenib versus interferon in patients with advanced renal cell carcinoma [abstract];Szczylik;J Clin Oncol,2007
Cited by
156 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献